Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma III: Clinical Manifestations

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pulmonary aspergillosis: a clinical review.

European respiratory review : an official journal of the European Respiratory Society·2011

Same author

Non-caseating granulomas in patients after the diagnosis of cancer: clinical characteristics and outcome.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2011

Same author

A patient with recurrent pneumonia: think outside the box.

QJM : monthly journal of the Association of Physicians·2010

Same author

Complications of thoracentesis.

Internal medicine journal·2009

Same author

The evaluation and management of the solitary pulmonary nodule.

Postgraduate medical journal·2008

Same author

An unusual cause of increased abdominal girth.

QJM : monthly journal of the Association of Physicians·2008

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Pulmonary aspergillosis: a clinical update.

O S Zmeili¹, A O Soubani

¹Division of Pulmonary, Allergy, Critical Care and Sleep, Harper University Hospital, 3990 John R-3 Hudson, Detroit, MI 48201, USA.

QJM : Monthly Journal of the Association of Physicians

|May 26, 2007

Summary

Pulmonary aspergillosis encompasses diverse conditions like invasive, chronic, and allergic forms, influenced by immune status. Advances in diagnostics and new antifungal drugs improve patient outcomes for these Aspergillus-related lung diseases.

More Related Videos

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Related Experiment Videos

Last Updated: Jul 14, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Area of Science:

Pulmonology
Infectious Diseases
Mycology

Background:

Aspergillus species cause various pulmonary diseases, including invasive pulmonary aspergillosis, chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis.
Disease presentation and severity depend on patient immune status and underlying lung conditions.

Purpose of the Study:

To provide a clinical update on the epidemiology, risk factors, clinical presentation, diagnosis, and management of pulmonary aspergillosis.
To highlight recent advances in diagnostic methods and antifungal therapies.

Main Methods:

Review of current literature on pulmonary aspergillosis.
Synthesis of information on diagnostic tools and therapeutic agents.

Main Results:

Pulmonary aspergillosis manifests differently based on host factors, ranging from invasive to allergic forms.
New non-invasive diagnostic tests and novel antifungal agents (azoles, echinocandins) are improving patient management and outcomes.

Conclusions:

Pulmonary aspergillosis requires tailored management strategies based on specific clinical syndromes and patient immune status.
Recent advancements in diagnostics and therapeutics offer improved prospects for patients with these fungal lung infections.